Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

17/06/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.98%, closing at 51492.55 points; the Nasdaq Composite dropped by 1.34%, closing at 26021.66 points; the S&P 500 Index dropped by 1.21%, closing at 7420.1 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

uniQure N.V.: Overnight gain 78.4%, Surges on FDA Breakthrough for Huntington's Disease Therapy AMT-130

uniQure N.V. is a private limited liability company incorporated under Dutch law on January 9, 2012, specializing in biotechnology development within the gene therapy sector. The company is dedicated to providing single-treatment solutions for patients with rare diseases and severe medical conditions. The company's product pipeline encompasses multiple clinical-stage candidates, primarily targeting therapeutic areas including Huntington's disease, SOD1-mutation associated amyotrophic lateral sclerosis (ALS), refractory mesial temporal lobe epilepsy, and Fabry disease. The enterprise's specialized positioning demonstrates its strategic focus and technical capabilities in developing innovative gene therapy treatments.

uniQure N.V. (QURE) shares surged following significant regulatory breakthrough for its core asset. The FDA formally accepted the company's 3-year Phase I/II clinical data for AMT-130 Huntington's disease therapy as the foundation for accelerated approval, establishing a clear commercialization timeline with biologics license application submission planned for Q3 2026. The therapy enjoys comprehensive regulatory advantages, securing the first Regenerative Medicine Advanced Therapy (RMAT) designation in Huntington's disease, alongside Breakthrough Therapy and Fast Track designations. During the Type B meeting, FDA confirmed the accelerated approval pathway and committed to collaborative engagement throughout the review process, substantially reducing regulatory uncertainty. As a rare disease gene therapy specialist, uniQure N.V. (QURE) targets the highly unmet medical need in Huntington's disease market. Upon approval, AMT-130 presents significant commercial potential. These positive developments collectively drive investor optimism regarding the company's prospects, contributing to the stock's upward momentum.

AstroNova, Inc.: Overnight gain 69.9%, Surges on Arcline Acquisition Agreement with Premium Cash Offer

AstroNova, Inc. is a specialized technology company focused on the design, development, manufacturing, and commercialization of professional printing equipment and data acquisition and analysis systems. The company delivers integrated hardware and software solutions that leverage advanced technologies to enable multi-format data collection, storage, analysis, and visualization capabilities. The company's product portfolio serves a diversified range of end markets, including aerospace and defense, textiles and apparel, automotive manufacturing, avionics, chemicals, computer peripherals, telecommunications, distribution, food and beverage, industrial manufacturing, packaging, and logistics and transportation sectors. AstroNova employs a multi-channel global distribution strategy to achieve international market penetration, utilizing a combination of direct sales teams, authorized distributors, independent dealers, and sales representatives to optimize market coverage and customer reach across its target geographies.

AstroNova, Inc. (ALOT) shares surged 69.9% following the announcement of a definitive acquisition agreement with Arcline Investment Management. Under the all-cash transaction, Arcline will acquire AstroNova for $29.00 per share, representing a total enterprise value of approximately $272 million and a significant premium to previous trading levels. The transaction, unanimously approved by AstroNova's Board of Directors, provides shareholders with certainty of returns while eliminating completion risk through its all-cash structure. As a specialized manufacturer of data acquisition and printing equipment serving critical sectors including aerospace, automotive, and telecommunications, AstroNova's technical expertise and established customer base are reflected in the acquisition premium. This strategic transaction resulted from the company's comprehensive review of alternatives aimed at maximizing shareholder value. Management's endorsement of the acquisition as the optimal path forward under current market conditions has further bolstered investor confidence in the deal's completion prospects.

Hyperscale Data, Inc.: Overnight gain 53.0%, Surges Amid Billion-Dollar AI Data Center Negotiations and Strategic Transformation

Hyperscale Data, Inc. is a Delaware-incorporated corporation that specializes in data center ownership and operations through its wholly-owned and majority-owned subsidiaries, as well as strategic investment portfolio. The company's core business activities encompass Bitcoin mining operations and the provision of specialized colocation services to the artificial intelligence ecosystem and related industries. Additionally, the enterprise delivers mission-critical solutions across multiple vertical markets, including metaverse platform development, oil exploration technologies, crane machinery services, defense contracting, manufacturing, automotive, healthcare, consumer electronics manufacturing, and textile industries, representing a diversified commercial portfolio.

Hyperscale Data, Inc. (GPUS) shares surged 53% driven by multiple positive catalysts. The company is in advanced negotiations for an AI data center services agreement exceeding $1 billion, providing 20 megawatts of AI computing capacity in Michigan. Including a 32-megawatt expansion plan through 2028, the total 20-year contract value could surpass $2.5 billion. Additionally, Hyperscale Data, Inc. (GPUS) secured a $15 million advance payment from Yorkville, providing funding support for data center development. The company's strategic pivot from traditional Bitcoin mining to high-margin AI infrastructure services aligns with current market trends. The firm maintains a solid asset base, holding approximately 713 Bitcoin (valued at $46.9 million) and $40.2 million in cash, representing 73.34% of market capitalization. Short interest declined from 41.89 million to 27.35 million shares, reflecting improved market sentiment and contributing to the significant price appreciation.

The Top 10 Daily Gainers in the USA market are listed as follows: